Industry & Policy News

[Philips] The Innovative Health Initiative has awarded a EUR 24 million grant to the IMAGIO consortium of clinical partners coordinated by Philips, with additional resources and funding from industry partners.

[Takeda] Takeda and HUTCHMED Limited announced that the European Medicines Agency has validated and accepted for regulatory review the marketing authorization application for fruquintinib, a highly selective and potent inhibitor of vascular endothelial growth factor receptors-1, -2, and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer.

[CTBio] SCTbio and Cyto-care.eu GmbH, a company that specializes in providing advanced solutions for cell therapy and regenerative medicine, have signed a collaboration agreement to improve the quality of cryopreservation for cell therapy development in Europe.

[News Medical Life Sciences] Funding announced by the Ontario Institute for Cancer Research (OICR) will help six Ontario-based research teams pursue their ultimate goal of improving the lives of people with cancer.

[Stony Brook University] Benjamin Martin, PhD, Associate Professor in the Department of Biochemistry and Cell Biology at Stony Brook University, and member of the Stony Brook University Cancer Center, has received a $2 million grant from the National Institutes of Health’s National Institute of General Medical Sciences to conduct research to understand the molecular and cell biology of neuromesodermal progenitors.

[Science Insider] Many U.S. biomedical researchers and their collaborators abroad are reacting with alarm to a new NIH requirement that foreign groups send their NIH partners copies of their lab notebooks and other raw data at least every few months.